Tarsus Pharmaceuticals
TARS
TARS
191 hedge funds and large institutions have $2.24B invested in Tarsus Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 67 increasing their positions, 71 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
6% less repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 71
1% less funds holding
Funds holding: 193 → 191 (-2)
22% less funds holding in top 10
Funds holding in top 10: 9 → 7 (-2)
Holders
191
Holding in Top 10
7
Calls
$1.39M
Puts
$627K
Top Buyers
| 1 | +$76.2M | |
| 2 | +$46.9M | |
| 3 | +$36.9M | |
| 4 |
O
OrbiMed
New York
|
+$33.6M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$26.2M |
Top Sellers
| 1 | -$20.4M | |
| 2 | -$19.8M | |
| 3 | -$17.6M | |
| 4 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$12.4M |
| 5 |
PA
Perceptive Advisors
New York
|
-$10.3M |